Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory B-cell Malignancies

Explore clinical trials studying Relapsed/Refractory B-cell Malignancies. Study availability and eligibility vary by location and protocol.

9 public trials 6 recruiting studies

Relapsed/Refractory B-cell Malignancies trial results

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • The First Affiliated Hospital of USTC west district Hefei, Anhui, China
  • Beijing Gobroad Boren Hospita Beijing, Beijing Municipality, China
  • The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • The First Affiliated Hospital of ZHENGZHOU University Zhengzhou, Henan, China
Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Gabrail Cancer Center Canton, Oklahoma, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • MICS Centrum Medyczne Toruń Torun, Kuyavian-Pomeranian Voivodeship, Poland
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • CHRU de Lille Lille, Nord, France
  • Hopital Saint Eloi Montpellier, France
  • Centre Hospitalier Lyon Sud Pierre-Bénite, France
  • University Hospital of Wales Cardiff, United Kingdom